As of 2026-03-16, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 5.45 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.37 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is 61.6%.
The range of the Relative Valuation is 3.37 - 7.55 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.8x - 25.6x | 24.2x |
| Forward P/E multiples | 21.6x - 23.0x | 22.3x |
| Fair Price | 3.37 - 7.55 | 5.45 |
| Upside | -0.1% - 124.1% | 61.6% |
| Date | P/E |
| 2026-03-13 | 22.83 |
| 2026-03-12 | 22.89 |
| 2026-03-11 | 24.93 |
| 2026-03-10 | 25.06 |
| 2026-03-09 | 24.72 |
| 2026-03-06 | 23.71 |
| 2026-03-05 | 24.52 |
| 2026-03-04 | 25.33 |
| 2026-03-03 | 24.66 |
| 2026-03-02 | 24.18 |
| 2026-02-27 | 23.17 |
| 2026-02-26 | 24.79 |
| 2026-02-25 | 22.76 |
| 2026-02-24 | 25.67 |
| 2026-02-23 | 25.40 |
| 2026-02-20 | 26.82 |
| 2026-02-19 | 31.23 |
| 2026-02-18 | 32.38 |
| 2026-02-17 | 32.38 |
| 2026-02-13 | 30.48 |
| 2026-02-12 | 31.23 |
| 2026-02-11 | 30.07 |
| 2026-02-10 | 31.09 |
| 2026-02-09 | 32.78 |
| 2026-02-06 | 30.89 |
| 2026-02-05 | 30.14 |
| 2026-02-04 | 30.38 |
| 2026-02-03 | 32.45 |
| 2026-02-02 | 33.46 |
| 2026-01-30 | 33.12 |
| 2026-01-29 | 32.92 |
| 2026-01-28 | 32.45 |
| 2026-01-27 | 34.82 |
| 2026-01-26 | 35.09 |
| 2026-01-23 | 35.43 |
| 2026-01-22 | 36.51 |
| 2026-01-21 | 35.97 |
| 2026-01-20 | 31.02 |
| 2026-01-16 | 30.48 |
| 2026-01-15 | 30.62 |
| 2026-01-14 | 30.75 |
| 2026-01-13 | 31.43 |
| 2026-01-12 | 30.28 |
| 2026-01-09 | 27.50 |
| 2026-01-08 | 26.96 |
| 2026-01-07 | 27.64 |
| 2026-01-06 | 29.13 |
| 2026-01-05 | 31.09 |
| 2026-01-02 | 28.92 |
| 2025-12-31 | 22.83 |